Gut Microbiota: Diet, Inflammation, and Homeostasis
Received: 01-May-2025 / Manuscript No. JMIR-25-176751 / Editor assigned: 05-May-2025 / PreQC No. JMIR-25-176751 / Reviewed: 19-May-2025 / QC No. JMIR-25-176751 / Revised: 22-May-2025 / Manuscript No. JMIR-25-176751 / Published Date: 29-May-2025
Abstract
This data explores the relationship between gut microbiota and intestinal health. It covers various aspects such as dietary influence, the role of probiotics, and the effects of environmental toxins. The inflammasome pathway, Short-chain \textit{Fatty Acids} (SCFAs), bile acids, the vagus nerve, and postbiotics are also examined for their roles in gut health, offering a comprehensive view of factors impacting gut homeostasis.
Keywords
Gut microbiota;Inflammatory Bowel Disease (IBD);Probiotics;Postbiotics;Short-chain Fatty Acids (SCFAs);Intestinal permeability;Inflammation;Diet;Vagus nerve;Bile acids
Introduction
The gut microbiota, a complex community of microorganisms residing in the gastrointestinal tract, plays a pivotal role in human health and disease. Recent research has illuminated the intricate ways in which this microbial ecosystem interacts with the host, influencing everything from immune function to metabolic processes. Diet is a key modulator of gut microbiota composition and function, and dietary factors can significantly impact gut barrier integrity and inflammatory responses [1].
Specific nutrients and food components can alter the balance of the intestinal microbiota, affecting both mucosal integrity and the severity of inflammatory conditions. Inflammatory Bowel Disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, and the gut microbiota is now recognized as a central player in its pathogenesis [2].
Specific microbial species and their metabolites can either exacerbate or alleviate intestinal inflammation. Certain bacterial strains can enhance tight junction protein expression and reduce intestinal permeability, thereby reinforcing the mucosal barrier [3].
Conversely, environmental toxins can disrupt epithelial cell junctions and trigger inflammatory cascades in the gut, leading to increased intestinal permeability and inflammation [4].
The inflammasome pathway, a key component of the innate immune system, also plays a crucial role in driving intestinal inflammation [5].
Specific inflammasome components are activated in response to microbial dysbiosis and contribute to IBD pathogenesis. Understanding how the intestinal microbiota interacts with the host immune system is essential for maintaining gut homeostasis and preventing inflammatory diseases [6].
Short-chain Fatty Acids (SCFAs), produced by microbial fermentation, can strengthen epithelial cell junctions and suppress inflammatory pathways, thereby promoting gut barrier integrity and reducing inflammation [7].
Bile acids can modulate intestinal permeability and activate inflammatory signaling pathways, influencing gut barrier function and inflammatory responses [8].
Furthermore, the vagus nerve plays a role in modulating gut inflammation and barrier function [9].
Vagal nerve stimulation can suppress inflammatory responses and enhance mucosal integrity. Postbiotics, non-viable bacterial products, offer a promising approach to modulate inflammatory pathways and enhance gut barrier function without the risks associated with live bacteria [10].
Description
Dietary factors significantly influence gut barrier function and inflammatory responses [1]. Specific nutrients and food components modulate the intestinal microbiota, affecting mucosal integrity and the severity of inflammatory conditions. The gut microbiota plays a central role in Inflammatory Bowel Disease (IBD) [2]. Microbial species and their metabolites can either exacerbate or alleviate intestinal inflammation. Probiotics can reinforce mucosal barrier function [3]. Specific bacterial strains enhance tight junction protein expression and reduce intestinal permeability. Environmental toxins disrupt epithelial cell junctions and trigger inflammatory cascades in the gut [4]. These toxins increase intestinal permeability and inflammation.
The inflammasome pathway drives intestinal inflammation [5]. Specific inflammasome components are activated in response to microbial dysbiosis and contribute to IBD pathogenesis. The intestinal microbiota interacts with the host immune system, maintaining gut homeostasis and preventing inflammatory diseases [6]. Short-chain Fatty Acids (SCFAs) impact gut barrier integrity and inflammation [7]. SCFAs, produced by microbial fermentation, strengthen epithelial cell junctions and suppress inflammatory pathways. Bile acids influence gut barrier function and inflammatory responses [8]. Bile acids modulate intestinal permeability and activate inflammatory signaling pathways.
The vagus nerve modulates gut inflammation and barrier function [9]. Vagal nerve stimulation suppresses inflammatory responses and enhances mucosal integrity. Postbiotics influence gut health [10]. These non-viable bacterial products modulate inflammatory pathways and enhance gut barrier function without the risks associated with live bacteria. These findings underscore the importance of understanding the complex interplay between diet, the gut microbiota, and the host immune system in maintaining gut health and preventing inflammatory diseases.
Targeting the gut microbiota through dietary interventions, probiotics, or postbiotics may offer promising therapeutic strategies for managing IBD and other inflammatory conditions. Further research is needed to elucidate the precise mechanisms by which these interventions exert their beneficial effects and to identify the most effective strategies for manipulating the gut microbiota to promote gut health.
Conclusion
The gut microbiota is a complex ecosystem that plays a critical role in human health, influencing immune function, metabolic processes, and susceptibility to diseases like Inflammatory Bowel Disease (IBD). Diet is a key factor shaping the gut microbiota, with specific nutrients and food components capable of modulating its composition and function. This modulation can affect the gut barrier, which protects the body from harmful substances, and influence inflammatory responses. Certain microbial species and their metabolites can either worsen or alleviate intestinal inflammation, highlighting the delicate balance within the gut ecosystem. Probiotics, containing beneficial bacteria, can reinforce the mucosal barrier by enhancing tight junction protein expression and reducing intestinal permeability. Conversely, environmental toxins can disrupt epithelial cell junctions, triggering inflammatory cascades and increasing intestinal permeability. The inflammasome pathway, part of the innate immune system, also contributes to intestinal inflammation by activating in response to microbial imbalances. The interactions between the gut microbiota and the host immune system are crucial for maintaining gut homeostasis and preventing inflammatory diseases. Short-chain Fatty Acids (SCFAs), produced through microbial fermentation, strengthen epithelial cell junctions and suppress inflammatory pathways. Bile acids can modulate intestinal permeability and activate inflammatory signaling pathways, further influencing gut health. The vagus nerve plays a role in modulating gut inflammation, with vagal nerve stimulation suppressing inflammatory responses and enhancing mucosal integrity. Postbiotics, non-viable bacterial products, offer a potential strategy to modulate inflammatory pathways and enhance gut barrier function without the risks associated with live bacteria. Understanding these complex interactions is essential for developing effective strategies to promote gut health and prevent inflammatory diseases.
References
- Gregory JG, David MD, David AS (2022) .Nutrients 14:4343.
, ,
- Alan L, Harry S (2020) .Gut 69:683-696.
, ,
- Ying Z, Shuwen L, Rui G (2023) .Int J Mol Sci 24:12496.
, ,
- Alessio F (2020) .Ann N Y Acad Sci 1417:5-14.
, ,
- Bo H, Eran E (2017) .Immunity 47:199-201.
, ,
- Hong-tao JW, Eran W (2012) .Gut Microbes 3:4-14.
, ,
- Chang HK (2018) .Nutrients 10:1813.
, ,
- Xiaojing S, Xin S, Stephan FO (2020) .Physiol Rev 100:467-503.
, ,
- Gaia M, María GdA, Marta VC (2014) .Nat Commun 5:4918.
, ,
- Jose EA, Rocio G, Hugo SG (2018) .Trends Food Sci Technol 75:105-114.
, ,
Citation: Mendieta C (2025) Gut Microbiota: Diet, Inflammation, and Homeostasis . J Mucosal Immunol Res 09: 299.
Copyright: 漏 2025 Clara Mendieta This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 347
- [From(publication date): 0-0 - Apr 06, 2026]
- Breakdown by view type
- HTML page views: 290
- PDF downloads: 57
